Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Francomano Robert	2. Date of Event Requiring Statement (MM/DD/YYYY) 12/6/2019	3. Issuer Name and Ticker or Trading Symbol STEMLINE THERAPEUTICS INC [STML]
(Last)        (First)        (Middle) 750 LEXINGTON AVENUE, ELEVENTH FLOOR	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Chief Commercial Officer /
(Street) NEW YORK, NY 10022       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	100991 (1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(2)	9/19/2026	Common Stock	50000	$9.79	D

Explanation of Responses:
(1)	Includes 61,332 shares of restricted stock.
(2)	Represents options vest equally on 09/19/2017, 09/19/2018, 09/19/2019 and 09/19/2020, subject to the terms of the award agreement.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Francomano Robert 750 LEXINGTON AVENUE, ELEVENTH FLOOR NEW YORK, NY 10022			Chief Commercial Officer

Signatures
/s/ Kenneth Hoberman, Attorney-in-Fact		12/23/2019
**Signature of Reporting Person		Date